Delivery Order SPE2DB22D3301-SPE2DB25FY3CG
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,206.90 firm fixed-price delivery order is for the supply of 4,564,852,598 units of Fexofenadine HCl 180 mg tablets. The contract has an ultimate completion date of June 11, 2024 and was awarded on June 10, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This is a $1,903.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4,563,346,371 units of Fexofenadine HCL 180 mg Tablets. The contract has a period of performance through January 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,180.81 firm-fixed-price delivery order is for the supply of 4,565,962,852 units of Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of September 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,146,216 units of the medication Fexofenadine HCL 180 mg tablet. The award has a ceiling value of $3,343.20 and is a firm fixed-price contract. The period of performance extends to May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,014.35 firm-fixed-price delivery order is for the supply of 4,564,016,983 units of Fexofenadine HCl 180 mg tablets, a medication used to treat allergies. The contract has an ultimate completion date of March 20, 2024 and was awarded on March 19, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,845.00, is for the delivery of fexofenadine HCl 180 mg tablets. The contract has an ultimate completion date of March 25, 2025 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,159.51, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,946.16 Firm Fixed Price delivery order is for the supply of 4,566,658,080 units of Fexofenadine HCL 180 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), for the supply of 4,564,109,278 units of Fexofenadine HCL 180 mg tablets. The order has a firm fixed price of $13,468.26 and a performance period ending on March 29, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, through a DLA indefinite delivery contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,543.66, is for the delivery of 4,562,823,947 tablets of Fexofenadine HCL 180 mg. The contract has an ultimate completion date of November 16, 2023 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY3CGDelivery Order
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,673.88 firm fixed-price delivery order is for the supply of 4,567,886,379 units of the drug Fexofenadine HCL 180 mg tablets. The contract has an ultimate completion date of April 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC, which runs through November 2026, serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 4/11/25 |